177 related articles for article (PubMed ID: 32452023)
1. The role of HSP90 molecular chaperones in hepatocellular carcinoma.
Nouri-Vaskeh M; Alizadeh L; Hajiasgharzadeh K; Mokhtarzadeh A; Halimi M; Baradaran B
J Cell Physiol; 2020 Dec; 235(12):9110-9120. PubMed ID: 32452023
[TBL] [Abstract][Full Text] [Related]
2. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
3. HSP90 interacts with HMGCR and promotes the progression of hepatocellular carcinoma.
Dong L; Xue L; Zhang C; Li H; Cai Z; Guo R
Mol Med Rep; 2019 Jan; 19(1):524-532. PubMed ID: 30483734
[TBL] [Abstract][Full Text] [Related]
4. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
[TBL] [Abstract][Full Text] [Related]
5. Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma.
Augello G; Emma MR; Cusimano A; Azzolina A; Mongiovì S; Puleio R; Cassata G; Gulino A; Belmonte B; Gramignoli R; Strom SC; McCubrey JA; Montalto G; Cervello M
Int J Cancer; 2019 May; 144(10):2613-2624. PubMed ID: 30488605
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 5-aryl-3-thiophen-2-yl-1H-pyrazoles as a new class of Hsp90 inhibitors in hepatocellular carcinoma.
Mohamady S; Ismail MI; Mogheith SM; Attia YM; Taylor SD
Bioorg Chem; 2020 Jan; 94():103433. PubMed ID: 31785857
[TBL] [Abstract][Full Text] [Related]
7. Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules.
Lim SO; Park SG; Yoo JH; Park YM; Kim HJ; Jang KT; Cho JW; Yoo BC; Jung GH; Park CK
World J Gastroenterol; 2005 Apr; 11(14):2072-9. PubMed ID: 15810071
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between abnormal expression of heat shock protein 90 and malignant transformation of hepatocytes].
Su XQ; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2006 Apr; 14(4):314-7. PubMed ID: 16635315
[No Abstract] [Full Text] [Related]
9. Role of the novel HSP90 inhibitor AUY922 in hepatocellular carcinoma: Potential for therapy.
Cheng W; Ainiwaer A; Xiao L; Cao Q; Wu G; Yang Y; Mao R; Bao Y
Mol Med Rep; 2015 Aug; 12(2):2451-6. PubMed ID: 25955495
[TBL] [Abstract][Full Text] [Related]
10. Impact of Posttranslational Modifications on the Anticancer Activity of Hsp90 Inhibitors.
Woodford MR; Dunn D; Miller JB; Jamal S; Neckers L; Mollapour M
Adv Cancer Res; 2016; 129():31-50. PubMed ID: 26916000
[TBL] [Abstract][Full Text] [Related]
11. 17-Demethoxy-reblastatin, an Hsp90 inhibitor, induces mitochondria-mediated apoptosis through downregulation of Mcl-1 in human hepatocellular carcinoma cells.
Zhao S; Li H; Jiang C; Ma T; Wu C; Huo Q; Liu H
J Bioenerg Biomembr; 2015 Oct; 47(5):373-81. PubMed ID: 26323360
[TBL] [Abstract][Full Text] [Related]
12. Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy.
Ji F; Zhang Y; Zhu ZB; Guo Y; Shen SL; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
Hum Pathol; 2019 Apr; 86():193-202. PubMed ID: 30529751
[TBL] [Abstract][Full Text] [Related]
13. Hsp90: a chaperone for protein folding and gene regulation.
Zhao R; Houry WA
Biochem Cell Biol; 2005 Dec; 83(6):703-10. PubMed ID: 16333321
[TBL] [Abstract][Full Text] [Related]
14. Hsp90--from signal transduction to cell transformation.
Brown MA; Zhu L; Schmidt C; Tucker PW
Biochem Biophys Res Commun; 2007 Nov; 363(2):241-6. PubMed ID: 17826744
[TBL] [Abstract][Full Text] [Related]
15. 17-DMAG induces heat shock protein 90 functional impairment in human bladder cancer cells: knocking down the hallmark traits of malignancy.
Karkoulis PK; Stravopodis DJ; Voutsinas GE
Tumour Biol; 2016 May; 37(5):6861-73. PubMed ID: 26662567
[TBL] [Abstract][Full Text] [Related]
16. The Hsp90 inhibitor SNX-2112 induces apoptosis of human hepatocellular carcinoma cells: the role of ER stress.
Wang X; Wang S; Liu Y; Ding W; Zheng K; Xiang Y; Liu K; Wang D; Zeng Y; Xia M; Yang D; Wang Y
Biochem Biophys Res Commun; 2014 Mar; 446(1):160-6. PubMed ID: 24582562
[TBL] [Abstract][Full Text] [Related]
17. Heat-shock protein 90 inhibitors in cancer therapy: 17AAG and beyond.
Georgakis GV; Younes A
Future Oncol; 2005 Apr; 1(2):273-81. PubMed ID: 16555999
[TBL] [Abstract][Full Text] [Related]
18. HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer Therapy.
Condelli V; Crispo F; Pietrafesa M; Lettini G; Matassa DS; Esposito F; Landriscina M; Maddalena F
Cells; 2019 Jun; 8(6):. PubMed ID: 31163702
[TBL] [Abstract][Full Text] [Related]
19. Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach.
Chatterjee S; Burns TF
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914774
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Hsp90 regulation.
Prodromou C
Biochem J; 2016 Aug; 473(16):2439-52. PubMed ID: 27515256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
